Here, we reported that SLC12A5 could induce ER stress to promote tumor progression and ferroptosis resistance; alternatively, VU0240551, a SLC12A5 inhibitor, could induce ferroptosis via the down‐regulation of xCT. Here, SLC12A5 is linked to neoplasm.